Study results indicate that the latest-generation design of Bioventus’ EXOGEN® Ultrasound Bone Healing System improves patient compliance by 10%, with overall compliance at a minimum of 76%. The device employs low-intensity pulsed ultrasound to help stimulate the natural healing process.
The next-generation device, which launched in 2014, features a compliance calendar. Among 12,984 patient data files analyzed, compliance was 84% vs. a rate of 74% with the previous model. Further, incorporation of the calendar resulted in compliance never decreasing below 76% over the 6-month analysis.
Researchers also analyzed 12 clinical trials on the ultrasound technology for which compliance was recorded. In eight of these studies that met endpoints, compliance was 88%. If the primary endpoint was unmet, compliance averaged 54%.
Study results indicate that the latest-generation design of Bioventus' EXOGEN® Ultrasound Bone Healing System improves patient compliance by 10%, with overall compliance at a minimum of 76%. The device employs low-intensity pulsed ultrasound to help stimulate the natural healing process.
The next-generation device, which launched in 2014,...
Study results indicate that the latest-generation design of Bioventus’ EXOGEN® Ultrasound Bone Healing System improves patient compliance by 10%, with overall compliance at a minimum of 76%. The device employs low-intensity pulsed ultrasound to help stimulate the natural healing process.
The next-generation device, which launched in 2014, features a compliance calendar. Among 12,984 patient data files analyzed, compliance was 84% vs. a rate of 74% with the previous model. Further, incorporation of the calendar resulted in compliance never decreasing below 76% over the 6-month analysis.
Researchers also analyzed 12 clinical trials on the ultrasound technology for which compliance was recorded. In eight of these studies that met endpoints, compliance was 88%. If the primary endpoint was unmet, compliance averaged 54%.
Copy to clipboard 
